Company Overview and News

to your dashboard

Headline News

McKesson unit wins $400 mln U.S. defense contract -Pentagon

4h reuters
WASHINGTON (Reuters) - McKesson Corp subsidiary McKesson Technologies LLC has been awarded a maximum $400 million contract for digital imaging network picture archiving communications system products and maintenance, the Pentagon said on Friday. (3-0)

Inside the Mad Dash to Bring You Cheap, Generic Viagra

15h bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world. (284-0)

Sales Growth Hurt McKesson (MCK) Rating

2017-12-13 investorplace
McKesson Corp (NYSE:MCK) is one of 81 companies within the Health Care Providers & Services GICS industry group, which is in turn part of the 782 company GICS Health Care sector. MCK's market value is $31.7 billion which places it in the top decile in its industry group. The ranking for MCK by Portfolio Grader places it 48 among the 81 companies in this industry group, giving it a lower than average position; in the third quartile of the sector with a ranking of 444 among the 782 companies in the sector, and number 2,708 in the nearly 5,000 company Portfolio Grader universe. (3-0)

Top 10 Net Payout Yields For December 2017

2017-12-13 seekingalpha
The top net payout yields had a very disappointing loss for November far underperforming the benchmark S&P 500. (34-0)

Valuation Dashboard: Healthcare - Update

2017-12-08 seekingalpha
This article series provides a monthly dashboard of industries in each sector of the GICS classification. It compares valuation and quality factors relative to their historical averages. (29-0)

Cardinal Health: In The Middle Of The Storm

2017-12-07 seekingalpha
Cardinal Health (NYSE:CAH) is one of the three leaders in pharmaceutical distribution with AmerisourceBergen (NYSE:ABC) and McKesson (NYSE:MCK). CAH operates under 2 business segments: the Pharmaceutical segment (89% of revenue) distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products; and the Medical segment (11% of revenue) distributes a range of medical, surgical and laboratory products, and provides services to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers. (56-0)

Stock of McKesson (MCK) Falls to Sell

2017-12-06 investorplace
With a $30.4 billion market value, McKesson Corp (NYSE:MCK) ranks in the top decile in its industry group, Health Care Providers & Services, and in the top 10% of its sector group, Health Care, in market value. From the vantage point of investment attractiveness, The current Portfolio Grader ranking for MCK puts it 56 among the 82 companies in this industry group, giving it a below-average spot; in the third quartile of the sector with a ranking of 526 among the 782 companies in the sector, and number 3,161 in the nearly 5,000 company Portfolio Grader universe. (3-0)

Becton, Dickinson Focuses on Medication Management, Stock Up

2017-12-06 zacks
Becton, Dickinson and Company (BDX - Free Report) , popularly known as BD, recently enhanced the medication management process through technological innovation. The company introduced innovative platforms like BD HealthSight viewer, BD Pyxis ES software and BD Alaris infusion solutions. These promise inventory optimization, availability, solid clinician productivity and complete medication safety to patients. (39-0)

Health care company McKesson Canada acquires online retailer

In this Jan. 31, 2008 file photo, is a sign at McKesson Corporation's corporate headquarters in San Francisco. California is shown. (AP Photo/Paul Sakuma, File) (3-0)

Cardinal Health - Speculation Has Created The Ultimate Buying Opportunity For This Dividend Aristocrat

2017-12-01 seekingalpha
Cardinal Health has a footprint that spans 24,000 pharmacies, 85% of U.S. Hospitals and 2 million home patients. (53-0)

Anti-Amazon: A Favorite Investment Theme For 2018

2017-11-30 seekingalpha
It’s that time of year again. Time for the analysts and pundits to start looking ahead and muse about their favorite investment themes for the coming year in 2018. Despite the fact that the turkey was just removed from the dining room table only a few days ago, there’s no better time than the present to get out front with a few outlook appetizers for the New Year investment buffet. So what's among my favorite investment themes for 2018? The “Anti-Amazon” trade. (298-1)

Industry Group Rank Analytics Limit McKesson (MCK) Ratings Upgrade to Hold

2017-11-29 investorplace
The current recommendation of Hold for McKesson Corp (NYSE:MCK) is computed using the methodology of Louis Navellier for investing and his Portfolio Grader stock evaluator. The current overall Portfolio Grader recommendation on the shares has changed twice in the past month, which represents a greater level of change than is typical. (3-0)

Healthcare Weighs On Global Moats

2017-11-29 seekingalpha
Global moat stocks trailed their respective broad markets in October. International moats, as represented by the Morningstar® Global ex-US Moat Focus IndexSM (MGEUMFUN, or "International Moat Index"), ended the month in negative territory with a return of -0.80% compared to 1.88%% for the MSCI All Country World Index ex-USA (MSCI ACWI ex-USA). The U.S.-oriented Morningstar® Wide Moat Focus IndexSM (MWMFTR, or "U. (98-1)

Top 10 Net Payout Yields For November 2017

2017-11-28 seekingalpha
The top net payout yields had a very disappointing loss for October far underperforming the benchmark S&P 500. (121-1)

Free Post Earnings Research Report: McKesson's Revenue Grew 4%; Adjusted EPS Advanced 11%

2017-11-28 accesswire
LONDON, UK / ACCESSWIRE / November 28, 2017 / Active-Investors' free earnings report on McKesson Corp. (NYSE: MCK) has freshly been issued to its members. You can also sign up to view this report at McKesson reported its second quarter fiscal 2018 operating results on October 26, 2017. The Drug wholesaler exceeded top- and bottom-line expectations and provided earnings guidance for FY18. (42-0)

CUSIP: 58155Q103